Ken-ichi Fujita

Dr. Ken-ichi Fujita

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
KFKen-ichi Fujita
Ken-ichi Fujita
IKIsao Kubo
Isao Kubo

1 July 2011 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MYMasahiro Yutani
Masahiro Yutani
YHYukie Hashimoto
Yukie Hashimoto
AOAkira Ogita
Akira Ogita
IKIsao Kubo
Isao Kubo
TTToshio Tanaka
Toshio Tanaka
KFKen-ichi Fujita
Ken-ichi Fujita

1 May 2004 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
TKTetsuo Kiso
Tetsuo Kiso
KFKen-ichi Fujita
Ken-ichi Fujita
XPXu Ping
Xu Ping
TTToshio Tanaka
Toshio Tanaka
MTMakoto Taniguchi
Makoto Taniguchi
The microtubule, which is one of the major targets of anthelmintics, anticancer drugs, and fungicides, is composed mainly of α- and β-tubulins. We focused on a unique characteristic of an Aspergillus nidulans benA33 mutant to screen for microtubule-disrupting antifungal agents. This mutant, which has a β-tubulin with a mutation of a single amino acid, undergoes mitotic arrest due to the formation of hyperstable microtubules at 37°C. The heat sensitivity of the mutant is remedied by some antimicrotubule agents. We found that an agar plate assay with the mutant was able to distinguish three types of microtubule inhibitors. The growth recovery zones of the mutant were formed around paper disks containing microtubule inhibitors, including four benzimidazoles, ansamitocin P-3, griseofulvin, and rhizoxin, on the agar plate at 37°C. Nocodazole, thiabendazole, and griseofulvin reversed the mitotic arrest of the mutant and promoted its hyphal growth. Ansamitocin P-3 and rhizoxin showed growth recovery zones around the growth-inhibitory zones. Benomyl and carbendazim also reversed mitotic arrest but produced weaker growth recovery than the aforementioned drugs. Other microtubule inhibitors, such as colchicine, Colcemid, paclitaxel, podophyllotoxin, TN-16, vinblastine, and vincristine, as well as some cytoskeletal inhibitors tested, did not show such activity. In our screening, we newly identified two mycotoxins, citrinin and patulin, two sesquiterpene dialdehydes, polygodial and warburganal, and four phenylalanine derivatives, arphamenine A, l -2,5-dihydrophenylalanine (DHPA), N -tosyl- l -phenylalanine chloromethylketone, and N -carbobenzoxy- l -phenylalanine chloromethyl ketone. In a wild-type strain of A. nidulans , DHPA caused selective losses of microtubules, as determined by fluorescence microscopy, and of both α- and β-tubulins, as determined by Western blot analysis. This screening method involving the benA33 mutant of A. nidulans is useful, convenient, and highly selective. The phenylalanine derivatives tested are of a novel type of microtubule-disrupting antifungal agents, producing an accompanying loss of tubulins, and are different from well-known tubulin inhibitors affecting the assembly of tubulin dimers into microtubules.

21 January 2014 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
KFKen-ichi Fujita
Ken-ichi Fujita
MTMiki Tatsumi
Miki Tatsumi
AOAkira Ogita
Akira Ogita
IKIsao Kubo
Isao Kubo
TTToshio Tanaka
Toshio Tanaka

1 October 2003 in Journal of Chemical Ecology
Verified
Journal Article
Closed access
PDF file
KFKen-ichi Fujita
Ken-ichi Fujita
IKIsao Kubo
Isao Kubo

1 February 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Open access
KFKen-ichi Fujita
Ken-ichi Fujita
TITakayuki Ishikura
Takayuki Ishikura
YJYui Jono
Yui Jono
YYYoshihiro Yamaguchi
Yoshihiro Yamaguchi
AOAkira Ogita
Akira Ogita
TTToshio Tanaka
Toshio Tanaka
Trans-Anethole (anethole), a major component of anise oil, has a broad antimicrobial spectrum and a weaker antimicrobial potency than other available antibiotics. When combined with polygodial, nagilactone E, and n-dodecanol, anethole has been shown to exhibit synergistic antifungal activity against a budding yeast, Saccharomyces cerevisiae, and a human opportunistic pathogenic yeast, Candida albicans. However, the mechanism underlying this synergistic effect of anethole has not been characterized. We studied this mechanism using dodecanol-treated S. cerevisiae cells and focusing on genes related to multidrug efflux. Although dodecanol transiently reduced the number of colony forming units, this recovered to levels similar to those of untreated cells with continued incubation beyond 24h. Reverse transcription polymerase chain reaction analysis revealed overexpression of an ATP-binding cassette (ABC) transporter gene, PDR5, in addition to a slight increase in PDR11, PDR12, and PDR15 transcriptions in dodecanol-treated cells. In the presence of anethole, these effects were attenuated and the fungicidal activity of dodecanol was extended. Dodecanol showed longer lasting fungicidal activity against a Δpdr5. In addition, Δpdr3 and Δlge1, lack transcription factors of PDR5 and PDR3, were partly and completely susceptible to dodecanol, respectively. Furthermore, combination of anethole with fluconazole was also found to exhibit synergy on C. albicans. These results indicated that although anethole reduced the transcription of several transporters, PDR5 expression was particularly relevant to dodecanol efflux. Anethole is expected to be a promising candidate drug for the inhibition of efflux by reducing the transcription of several ABC transporters.